Extent of lung involvement over severity of cardiac disease for the prediction of adverse outcome in COVID-19 patients with cardiovascular disease

International Journal of Cardiology

21 October Oct 2020 5 years ago
  • Andreini D, Conte E, Mushtaq S, Gigante C, Mancini ME, Annoni A, Stefanini G, Agalbato C, Cosentino N, Pontone G, Assanelli E, Pepi M
QR Code

Aim of the present study was to assess if the presence of high cardiovascular risk, left ventricle systolic dysfunction or elevated BNP or Troponin are able to independently predict the outcome of patients with known cardiac disease and COVID-19 pneumonia.

Reference

Andreini D, Conte E, Mushtaq S, Gigante C, Mancini ME, Annoni A, Stefanini G, Agalbato C, Cosentino N, Pontone G, Assanelli E, Pepi M. Extent of lung involvement over severity of cardiac disease for the prediction of adverse outcome in COVID-19 patients with cardiovascular disease. Int J Cardiol 2020 Oct 8;S0167-5273(20)33915-2.doi: 10.1016/j.ijcard.2020.10.006.

Go to PubMed